Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: PTI-125 for Mild-to-moderate Alzheimer's Disease Patients [Phase 2]
Phase 2 clinical trial for PTI-125 in mild-to-moderate Alzheimer's disease completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-03-25Clinical Trial Update: Long Term Extension Study Evaluating Safety, Tolerability and Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease [Phase 2]
Phase 2 long-term extension study evaluating ACC-001 in mild to moderate Alzheimer’s disease completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease [Phase 2]
Phase 2 trial assessing safety and efficacy of Leukine in Alzheimer's disease has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: Multimodal Biomarkers for Diagnosis and Prognosis in CAA [Phase 3]
Phase 3 trial investigating multimodal biomarkers for diagnosis and prognosis in cerebral amyloid angiopathy and related intracranial hemorr…
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 trial update on ORY-2001 for mild to moderate Alzheimer's disease, reporting safety and preliminary efficacy results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease [Phase 2]
Phase 2 dose-finding trial of E2609 in mild cognitive impairment and Alzheimer's-related dementia was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD [Phase 4]
Open-label Phase 4 trial evaluating rivastigmine patch in mild to moderate Alzheimer's disease patients with coexisting cerebrovascular dise…
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients [Phase 2]
Phase 2 trial update reporting safety, tolerability, and Abeta-specific antibody response for repeated intramuscular injections of adjuvante…
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Stimulating Neural Activity to Improve Blood Flow and Reduce Amyloid: Path to Clinical Trials [NA]
Clinical trial update on stimulating neural activity to improve blood flow and reduce amyloid related to Alzheimer disease; study completed …
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients. [Phase 3]
Phase 3 trial evaluating atorvastatin plus a cholinesterase inhibitor in Alzheimer's disease patients has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: Feasibility - Infinitome
Completed feasibility trial for Infinitome in Alzheimer disease; results posted 2021-02-17.
-
CLINICAL_TRIALS trial_result · 2021-02-11Clinical Trial Update: A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease [Phase 3]
Phase III trial evaluating the efficacy and safety of a donepezil transdermal patch for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease [Phase 3]
Phase 3 study evaluating elenbecestat (E2609) in early Alzheimer's disease was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Dementia [NA]
Clinical trial update on magnesium L-threonate for learning and memory in people with dementia, completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Topography Staging and Dual Phase Image Quantification of Tau PET in Cognitive Impairment Subjects [Phase 2]
Phase 2 clinical trial update on topography staging and dual-phase image quantification of tau PET in cognitive impairment subjects with Alz…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial assessed the safety of GRF6019 infusions in subjects with severe Alzheimer's disease; results have been posted afte…
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
An extension study of ANAVEX2-73 in mild to moderate Alzheimer's disease completed Phase 2.
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia [Phase 4]
Phase 4 trial evaluating the effect of choline alfoscerate on cognitive function in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]
A Phase 2 randomized, controlled trial evaluating CERE-110 in subjects with mild to moderate Alzheimer's disease has been completed.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: An Extension Study of V203-AD Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UB-311 [Phase 2]
Extension study update for UB-311 (V203-AD) in Alzheimer's disease; Phase 2 trial terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients [Phase 2]
Phase 2 trial update assessing safety and tolerability of repeated subcutaneous injections of CAD 106 in patients with mild Alzheimer's dise…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients [Phase 2]
Phase 2 trial evaluating safety and tolerability of repeated subcutaneous injections of CAD106 in Alzheimer's disease patients has been comp…
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI) [NA]
Altoida conducted a clinical trial to evaluate its computerized NMI marker as a potential marker for functional impairment in Alzheimer's di…
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease [Phase 2]
Phase 2 clinical trial update for [18F]THK-5351 PET imaging across Alzheimer's disease, mild cognitive impairment, and other neurodegenerati…
-
CLINICAL_TRIALS trial_result · 2020-12-11Clinical Trial Update: Aggression Prevention Training for Caregivers of Persons With Dementia (APT) [NA]
Clinical trial completed evaluating aggression prevention training for caregivers of persons with dementia; results posted in 2020.